Stephen Auvil is the senior vice president for technology transfer and commercialization at the Maryland Technology Development Corporation (TEDCO). TEDCO is a quasi-state organization that supports technology transfer in Maryland’s universities and federal labs. Prior to TEDCO, Stephen spent 17 years in university technology transfer at the University of Maryland, Baltimore County (UMBC) and the Johns Hopkins University. Prior to Johns Hopkins, Stephen worked for a couple of small medical device companies in a variety of roles. He started his career working in a university research laboratory. He earned a Bachelor of Science degree in Biology and Engineering Science from Loyola University in Maryland, a Master of Business Administration from the University of Baltimore, and a Master of Science in Biotechnology from the Johns Hopkins University.

Rob has been an engineer for NASA, an Operational Test Director/Test Pilot for the Marines, a Presidential Nuclear Strike Adviser and designed aircraft. He also has run aviation acquisition program, science and technology programs, developed strategic plans for the Navy and Marine Corps unmanned aviation and holds aviation patents.
Rob is the founder of Hop Flyt, an aviation design and manufacturing startup specializing in highly autonomous electric Vertical Take Off and Landing aircraft. He hopes to give people time back in their lives by drastically reducing commute times with on demand, point to point vertical takeoff and landing transportation.

Matthew Carroll, president and CEO of Immuta, is responsible for the growth and direction of the company. Prior to co-founding Immuta, Matt spent a decade analyzing the world’s most complex datasets while supporting multiple US Intelligence Community customers. He also served as CTO of CSC’s Defense & Intelligence Group, leading critical data fusion and analytics programs ($150M in revenue) while advising US Government leaders on data management and analytics issues. Matt served honorably as an Officer in the US Army, including tours in Iraq and Afghanistan.

Aimee is an experienced entrepreneur with a background in the technology, health care, education, retail and media industries. She is currently CEO of MileMarker, the leader in on the job, real-time mobile assessment software for apprentice training, initially in the medical market. She is also co-founder of BondTrue, a medical device start up, with its first patented device under development.

Prior, Aimee consulted with companies in the education, healthcare, technology and retail markets. She was also Vice President, Business Development at Educate (Sylvan Learning), Director, Finance for Discovery Communications and Vice President, Investment Banking for A.G. Edwards (now Wells Fargo).

As General Manager of Cell and Gene Therapy, Mr. Poltilove has overall P&L responsibility for the Thermo Fisher business segment, including long-range product line strategy, investment, and day-to-day business operations. Previously, he led a $350M business segment of Cell Biology reagents and instrumentation. Prior to joining Thermo Fisher, Mr. Poltilove served as the Director of Revenue Strategy & Operations for the Corporate Executive Board and held several roles with Johnson & Johnson. He holds Bachelor’s degrees in Chemical Engineering and Economics from MIT and an M.B.A. from Northwestern University.